Laminin C1 expression by uterine carcinoma cells is associated with tumor progression

Hiroyasu Kashima, Ren Chin Wu, Yihong Wang, Abdulrahman K. Sinno, Tsutomu Miyamoto, Tanri Shiozawa, Tian-Li Wang, Amanda Nickles Nickles Fader, Ie Ming Shih

Research output: Contribution to journalArticle

Abstract

Objectives Molecular markers associated with tumor progression in uterine carcinoma are poorly defined. In this study, we determine whether upregulation of LAMC1, a gene encoding extracellular matrix protein, laminin γ1, is associated with various uterine carcinoma subtypes and stages of tumor progression. Methods An analysis of the immunostaining patterns of laminin γ1 in normal endometrium, atypical hyperplasia, and a total of 150 uterine carcinomas, including low-grade and high-grade endometrioid carcinomas, uterine serous and clear cell carcinoma, was performed. Clinicopathological correlation was performed to determine biological significance. The Cancer Genome Atlas (TCGA) data set was used to validate our results. Results As compared to normal proliferative and secretory endometrium, for which laminin γ1 immunoreactivity was almost undetectable, increasing laminin C1 staining intensity was observed in epithelial cells from atypical hyperplasia to low-grade endometrioid to high-grade endometrioid carcinoma, respectively. Laminin γ1 expression was significantly associated with FIGO stage, myometrial invasion, cervical/adnexal involvement, angiolymphatic invasion and lymph node metastasis. Similarly, analysis of the endometrial carcinoma data set from TCGA revealed that LAMC1 transcript levels were higher in high-grade than those in low-grade endometrioid carcinoma. Silencing LAMC1 expression by siRNAs in a high-grade endometrioid carcinoma cell line did not affect its proliferative activity but significantly suppressed cell motility and invasion in vitro. Conclusions These data suggest that laminin γ1 may contribute to the development and progression of uterine carcinoma, likely through enhancing tumor cell motility and invasion. Laminin γ1 warrants further investigation regarding its role as a biomarker and therapeutic target in uterine carcinoma.

Original languageEnglish (US)
Pages (from-to)338-344
Number of pages7
JournalGynecologic Oncology
Volume139
Issue number2
DOIs
StatePublished - 2015

Fingerprint

Endometrioid Carcinoma
Carcinoma
Neoplasms
Atlases
Endometrium
Cell Movement
Hyperplasia
Genome
Extracellular Matrix Proteins
Endometrial Neoplasms
laminin gamma 1
laminin 1
Up-Regulation
Biomarkers
Lymph Nodes
Epithelial Cells
Staining and Labeling
Neoplasm Metastasis
Cell Line
Genes

Keywords

  • Endometrial carcinoma
  • Laminin
  • Pathogenesis
  • Pathology
  • Uterine carcinoma

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology
  • Medicine(all)

Cite this

Laminin C1 expression by uterine carcinoma cells is associated with tumor progression. / Kashima, Hiroyasu; Wu, Ren Chin; Wang, Yihong; Sinno, Abdulrahman K.; Miyamoto, Tsutomu; Shiozawa, Tanri; Wang, Tian-Li; Nickles Fader, Amanda Nickles; Shih, Ie Ming.

In: Gynecologic Oncology, Vol. 139, No. 2, 2015, p. 338-344.

Research output: Contribution to journalArticle

Kashima, Hiroyasu ; Wu, Ren Chin ; Wang, Yihong ; Sinno, Abdulrahman K. ; Miyamoto, Tsutomu ; Shiozawa, Tanri ; Wang, Tian-Li ; Nickles Fader, Amanda Nickles ; Shih, Ie Ming. / Laminin C1 expression by uterine carcinoma cells is associated with tumor progression. In: Gynecologic Oncology. 2015 ; Vol. 139, No. 2. pp. 338-344.
@article{4ceeefe12bdd42f1a95eb1c38f1c5c2a,
title = "Laminin C1 expression by uterine carcinoma cells is associated with tumor progression",
abstract = "Objectives Molecular markers associated with tumor progression in uterine carcinoma are poorly defined. In this study, we determine whether upregulation of LAMC1, a gene encoding extracellular matrix protein, laminin γ1, is associated with various uterine carcinoma subtypes and stages of tumor progression. Methods An analysis of the immunostaining patterns of laminin γ1 in normal endometrium, atypical hyperplasia, and a total of 150 uterine carcinomas, including low-grade and high-grade endometrioid carcinomas, uterine serous and clear cell carcinoma, was performed. Clinicopathological correlation was performed to determine biological significance. The Cancer Genome Atlas (TCGA) data set was used to validate our results. Results As compared to normal proliferative and secretory endometrium, for which laminin γ1 immunoreactivity was almost undetectable, increasing laminin C1 staining intensity was observed in epithelial cells from atypical hyperplasia to low-grade endometrioid to high-grade endometrioid carcinoma, respectively. Laminin γ1 expression was significantly associated with FIGO stage, myometrial invasion, cervical/adnexal involvement, angiolymphatic invasion and lymph node metastasis. Similarly, analysis of the endometrial carcinoma data set from TCGA revealed that LAMC1 transcript levels were higher in high-grade than those in low-grade endometrioid carcinoma. Silencing LAMC1 expression by siRNAs in a high-grade endometrioid carcinoma cell line did not affect its proliferative activity but significantly suppressed cell motility and invasion in vitro. Conclusions These data suggest that laminin γ1 may contribute to the development and progression of uterine carcinoma, likely through enhancing tumor cell motility and invasion. Laminin γ1 warrants further investigation regarding its role as a biomarker and therapeutic target in uterine carcinoma.",
keywords = "Endometrial carcinoma, Laminin, Pathogenesis, Pathology, Uterine carcinoma",
author = "Hiroyasu Kashima and Wu, {Ren Chin} and Yihong Wang and Sinno, {Abdulrahman K.} and Tsutomu Miyamoto and Tanri Shiozawa and Tian-Li Wang and {Nickles Fader}, {Amanda Nickles} and Shih, {Ie Ming}",
year = "2015",
doi = "10.1016/j.ygyno.2015.08.025",
language = "English (US)",
volume = "139",
pages = "338--344",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Laminin C1 expression by uterine carcinoma cells is associated with tumor progression

AU - Kashima, Hiroyasu

AU - Wu, Ren Chin

AU - Wang, Yihong

AU - Sinno, Abdulrahman K.

AU - Miyamoto, Tsutomu

AU - Shiozawa, Tanri

AU - Wang, Tian-Li

AU - Nickles Fader, Amanda Nickles

AU - Shih, Ie Ming

PY - 2015

Y1 - 2015

N2 - Objectives Molecular markers associated with tumor progression in uterine carcinoma are poorly defined. In this study, we determine whether upregulation of LAMC1, a gene encoding extracellular matrix protein, laminin γ1, is associated with various uterine carcinoma subtypes and stages of tumor progression. Methods An analysis of the immunostaining patterns of laminin γ1 in normal endometrium, atypical hyperplasia, and a total of 150 uterine carcinomas, including low-grade and high-grade endometrioid carcinomas, uterine serous and clear cell carcinoma, was performed. Clinicopathological correlation was performed to determine biological significance. The Cancer Genome Atlas (TCGA) data set was used to validate our results. Results As compared to normal proliferative and secretory endometrium, for which laminin γ1 immunoreactivity was almost undetectable, increasing laminin C1 staining intensity was observed in epithelial cells from atypical hyperplasia to low-grade endometrioid to high-grade endometrioid carcinoma, respectively. Laminin γ1 expression was significantly associated with FIGO stage, myometrial invasion, cervical/adnexal involvement, angiolymphatic invasion and lymph node metastasis. Similarly, analysis of the endometrial carcinoma data set from TCGA revealed that LAMC1 transcript levels were higher in high-grade than those in low-grade endometrioid carcinoma. Silencing LAMC1 expression by siRNAs in a high-grade endometrioid carcinoma cell line did not affect its proliferative activity but significantly suppressed cell motility and invasion in vitro. Conclusions These data suggest that laminin γ1 may contribute to the development and progression of uterine carcinoma, likely through enhancing tumor cell motility and invasion. Laminin γ1 warrants further investigation regarding its role as a biomarker and therapeutic target in uterine carcinoma.

AB - Objectives Molecular markers associated with tumor progression in uterine carcinoma are poorly defined. In this study, we determine whether upregulation of LAMC1, a gene encoding extracellular matrix protein, laminin γ1, is associated with various uterine carcinoma subtypes and stages of tumor progression. Methods An analysis of the immunostaining patterns of laminin γ1 in normal endometrium, atypical hyperplasia, and a total of 150 uterine carcinomas, including low-grade and high-grade endometrioid carcinomas, uterine serous and clear cell carcinoma, was performed. Clinicopathological correlation was performed to determine biological significance. The Cancer Genome Atlas (TCGA) data set was used to validate our results. Results As compared to normal proliferative and secretory endometrium, for which laminin γ1 immunoreactivity was almost undetectable, increasing laminin C1 staining intensity was observed in epithelial cells from atypical hyperplasia to low-grade endometrioid to high-grade endometrioid carcinoma, respectively. Laminin γ1 expression was significantly associated with FIGO stage, myometrial invasion, cervical/adnexal involvement, angiolymphatic invasion and lymph node metastasis. Similarly, analysis of the endometrial carcinoma data set from TCGA revealed that LAMC1 transcript levels were higher in high-grade than those in low-grade endometrioid carcinoma. Silencing LAMC1 expression by siRNAs in a high-grade endometrioid carcinoma cell line did not affect its proliferative activity but significantly suppressed cell motility and invasion in vitro. Conclusions These data suggest that laminin γ1 may contribute to the development and progression of uterine carcinoma, likely through enhancing tumor cell motility and invasion. Laminin γ1 warrants further investigation regarding its role as a biomarker and therapeutic target in uterine carcinoma.

KW - Endometrial carcinoma

KW - Laminin

KW - Pathogenesis

KW - Pathology

KW - Uterine carcinoma

UR - http://www.scopus.com/inward/record.url?scp=84952631354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952631354&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2015.08.025

DO - 10.1016/j.ygyno.2015.08.025

M3 - Article

C2 - 26343160

AN - SCOPUS:84952631354

VL - 139

SP - 338

EP - 344

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 2

ER -